{"id":577977,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2014-08-22] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-24","captureTimestamp":"2026-02-24T11:35:38.342000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-5.html","snippet":"Notice: Prescription Drug List (PDL): Multiple additions August 22, 2014 Our file number: 14-110337-38 The purpose of this Notice of Amendment is to notify the addition of Bosutinib, Eslicarbasepine acetate, Icatibant acetate, Oclacitinib maleate, Elosulfase alfa, and Afoxolaner…","rawSnapshotUrl":"/api/snapshots/raw/577977","browseUrl":"https://replay.healtharchive.ca/job-6/20260224113538/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-multiple-additions-5.html#ha_snapshot=577977","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}